Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Pine Valley Investments Ltd Liability Co

Pine Valley Investments Ltd Liability Co reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 7.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 829 shares of the medical equipment provider’s stock after selling 69 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in Intuitive Surgical were worth $280,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ISRG. Douglass Winthrop Advisors LLC raised its holdings in Intuitive Surgical by 8.7% during the 4th quarter. Douglass Winthrop Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock worth $846,000 after buying an additional 200 shares during the period. IPG Investment Advisors LLC lifted its position in shares of Intuitive Surgical by 106.0% in the 4th quarter. IPG Investment Advisors LLC now owns 4,065 shares of the medical equipment provider’s stock valued at $1,371,000 after acquiring an additional 2,092 shares in the last quarter. United Services Automobile Association acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $3,461,000. Mitchell Sinkler & Starr PA grew its position in Intuitive Surgical by 13.7% during the 4th quarter. Mitchell Sinkler & Starr PA now owns 1,622 shares of the medical equipment provider’s stock worth $547,000 after purchasing an additional 195 shares in the last quarter. Finally, Artisan Partners Limited Partnership raised its stake in Intuitive Surgical by 53.5% during the 4th quarter. Artisan Partners Limited Partnership now owns 63,851 shares of the medical equipment provider’s stock valued at $21,541,000 after purchasing an additional 22,264 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.5 %

ISRG stock traded up $2.08 during midday trading on Tuesday, hitting $402.11. The stock had a trading volume of 1,283,271 shares, compared to its average volume of 1,546,882. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The stock has a 50-day simple moving average of $385.39 and a 200 day simple moving average of $359.77. The firm has a market capitalization of $142.63 billion, a price-to-earnings ratio of 72.58, a P/E/G ratio of 5.15 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the firm earned $1.00 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Mizuho upped their price target on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Barclays lifted their target price on shares of Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Finally, Truist Financial upped their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $396.17.

Get Our Latest Research Report on Intuitive Surgical

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Marshall Mohr sold 108,790 shares of the company’s stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the sale, the vice president now directly owns 26,877 shares in the company, valued at $10,349,795.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, VP Fredrik Widman sold 5,041 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the completion of the sale, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Marshall Mohr sold 108,790 shares of the business’s stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the transaction, the vice president now directly owns 26,877 shares in the company, valued at $10,349,795.16. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 148,290 shares of company stock valued at $57,207,154. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.